In a recent Q&A hosted by Susan Thornton, CEO of the Cutaneous Lymphoma Foundation, a patient advocacy group, Dr. Kim shared her gratitude to clinical trial participants and emphasized the urgent need ...

But researchers at Zest Science say there are certain occasions when you may be better off not wearing them. They say wearing ...

But researchers at Zest Science say there are certain occasions when you may be better off not wearing them. They say wearing ...

The National Psoriasis Foundation will host its annual Commit to Cure gala on June 18, the organization’s largest fundraiser ...

Two final-year students at the Kwame Nkrumah University of Science and Technology (KNUST) have developed an innovative, ...

The phototherapy lamps market has been witnessing consistent growth due to increasing global health awareness and the rising demand for non-invasive treatment methods. These specialized lamps, used ...

The Food and Drug Administration (FDA) has approved Starjemza ® (ustekinumab-hmny), a biosimilar to Stelara ® (ustekinumab), for the treatment of various chronic inflammatory diseases. Starjemza, ...

Researchers have found in an exploratory phase IIb study that adding twice-weekly narrowband UVB phototherapy to oral ...

The disease burden of atopic dermatitis was high in pediatric patients, but factors affecting the burden differed between adolescents and children.

The Food and Drug Administration has designated Hadlima (adalimumab-bwwd) an interchangeable biosimilar to Humira (adalimumab).